Preliminary Program

Laboratories PLUS: what else is in the toolbox of COVID-19 public health measures?
- Dr Tarun Weeramanthri

Long-term effect of Covid-19 - Dr Vanessa Bryant

The value of Pathology and the quality systems in supporting contemporary medical practice
– Dr Lawrie Bott

Pathology and My Health Record
- Dr Paul Carroll 

Recent advances in the investigations and management of Type 2 Diabetes Mellitus
- Prof Timonthy Davis

Australian guidelines for the diagnosis and management of Primary Hyperparathyroidism - A/Prof Frances Milat (virtual)

The Utility of Biomarkers in Assessing Bone Turnover in Renal Osteodystrophy
- Dr Syazrah (Jaja) Salam (virtual)

1. Impact of isobaric steroids on 17-Hydroxyprogesterone Mass Spectrometry analysis - Mrs Kirsten Hoad
2. Detection and quantification of Microrna (Mirna) to distinguish between benign and malignant adrenocortical tumours. Re-vision for a future - Ms Anila Hashmi
3. Higher free thyroxine levels observed in euthyrotropinaemic individuals on thyroxine therapy are not explained by a method-dependent bias - Dr Ranita Siru
4. Thiopurine Methyltransferase: A three part odyssey to create a novel test - Ms Kate Lunn
5. Development and validation of an LCMSMS method for the analysis of histamine and 1-Methylhistamine in urine – Ms Maria Myriallaki

1. Macrotroponin in Fabry Disease: A case series - Mr Cankayan Suthaharen
2. Total Bilirubin assay differences may cause inconsistent treatment decisions in neonatal hyperbilirubinaemia – Mr David Thomas
3. IGM Paraprotein: An unexpected cause of an elevated lipaemic index on Siemens Atellica analysers - Dr Eloise Ward
4. Frequency of Hypophosphataemia following intravenous iron therapy – Ms Rachel Dennis
5. Choosing Wisely: Is inpatient folate testing in the era of folate fortification a wise use of resources? - Dr Amas Lee
6. Evaluation of serum creatine kinase reference intervals in women relative to age - Mr Kyle-Peter Wollbrandt (virtual)

1. Measurement of B citamins, Thiamine Pyrophosphate (Vitamin B1) and Pyridoxal-5’-Phosphate (Vitamin B6), in whole blood using LC-MS/MS - Dr Gabrielle Crisp
2. The validation and implementation of a Mass Spectrometry method for immunoglobulin subclasses – Ms Sarah Thomas
3. “Total Country CV” – Monitoring patients across Australia - A/Prof Graham Jones
   
4. Identification of functional vitamin D deficiency through the simultaneous measurement of 25(OH)D and 24,25(OH)2D by LC-MS/MS  - Prof Markus Herrmann (virtual)
   
5. Overestimation of aldosterone by direct immunoassay compared to LC-MS/MS and immunoassay post-extraction. Why is it so? - Ms Sheree Stoner (virtual)
6. Quality Assurance Program for 14c-Urea breath testing - Mr John Abcede (virtual)

1. A Survey on laboratory report tracing at a Sri Lankan teaching hospital for introducing an IT Solution for report viewing - Dr Udara Senarathne
2. Humoral Immune Response to three doses of Covid vaccines in a cohort of Sri Lankan healthcare workers - Dr Bolonghoge Dayanath
   
3. Evaluation of algorithms for patient based realtime quality control - Miss Chantelle Ebersohn
4. Patient based real time quality control using Bull’s algorithm in a tertiary care hospital - Dr Sarvatnida Shaikh (virtual)
5. Using a web application to assist clinicians in screening for primary aldosteronism - Miss Rachelle Liwayan (virtual)

Recent experiences of the WA Newborn Screening Program. What lies ahead? - Dr Simon Carrivick

Novel screening modality for patients with rare disorders including developmental delays
– Dr Dimitar Azmanov

The road to routine pharmacogenomic testing in clinical practice: Are we there yet? - Dr Sam Salman 

Introduction - Mr Peter Graham

Cases 1 - Ms Helen Martin

Cases 2 - Dr Joel Smith

Cases 3 - Dr Penny Coates (virtual)